2013

Sun 14th - 19th July Pullman Cairns Int'l North QLD Australia

Sponsors



  • Grunenthal Australia


  • Monash Institute of Pharmaceutical Sciences


  • Alkermes


  • QRx Pharma


  • ASCEPT


  • ASPET - Neuropharmacology Division


  • British Journal of Pharmacology


  • British Pharmacological Society


  • Ian Potter Foundation


  • International Society for Neurochemistry

COUNTDOWN

Follow us on Twitter

Keynote Speakers

International Speakers

xxxx

Professor Graeme Henderson

Graeme Henderson obtained a BSc (Hons) in Pharmacology from the University of Glasgow and a PhD in Neuropharmacology from the University of Aberdeen where he worked under the supervision of Hans Kosterlitz and John Hughes. He has held academic positions at the University of Loyola (Chicago, USA) and the University of Cambridge (UK).

He is currently a Full Professor of Pharmacology at the University of Bristol (UK) where he was Department Chair from 1991 – 1999. He has been a long serving office bearer in the British Pharmacological Society, serving laterly as Scientific Meetings Vice President and then as President of the Society from 2005-2007. More recently he has served as First Vice President of the International Union of Basic and Clinical Pharmacology (IUPHAR) since 2010. At the University of Bristol he teaches pharmacology to medical, dental, veterinary and science students.

He is an author of the pharmacology textbook, Rang & Dale’s ‘Pharmacology’ 7th edition, and a member of the Editorial Board of Current Opinion in Pharmacology. His research interests centre on how opioid drugs exert their profound effects on the brain. Current research (funded by the MRC and BBSRC, UK) focuses on the molecular and cellular mechanisms underlying opioid tolerance and on how perturbation of tolerance may contribute to acute, unexpected ‘overdose’ deaths in opioid addicts. He is a member of the Independent Scientific Committee on Drugs, a body which assesses the potential harm of recreational drugs. 

National Speakers




xxxxx

 

Professor Bernard Balleine

Professor Bernard Balleine’s research aims to understand the integration of cognitive and emotional processes in decision-making and the essential neural systems and circuits that mediate goal-directed and habitual actions. Professor Balleine received his BA with first class honours and the University Medal from the University of Sydney in 1987 and his Ph.D in comparative psychology from the University of Cambridge in 1993.

He was elected to a Research Fellowship at Jesus College Cambridge in 1993 and, in 1995, appointed Assistant Professor at the University of California, Los Angeles (UCLA), Associate Professor in 2000 and Full Professor in 2004. In 2005 he was appointed Director of Research in the Brain Research Institute at UCLA. 

He won an inaugural ARC Laureate Fellowship in 2009, was appointed to a Professorship at Sydney University and moved his laboratory to the Brain & Mind Research Institute at Sydney University.

 

 

Professor Arthur Christopoulos

Arthur Christopoulos is a Professor of Pharmacology and Senior Research Fellow of the National Health & Medical Research Council (NHMRC) of Australia. He is a leading international authority on the study of G protein-coupled receptors (GPCRs), in particular on modes of allosteric modulation and biased signaling of this receptor superfamily.  

He has published over 160 peer-reviewed papers, with primary contributions being the development of bioassays and analytical procedures that facilitate the detection and quantification of allosteric drug effects and ligand-biased signaling.  

He has delivered over 100 invited conference/seminar presentations, including Gordon Research Conferences, Experimental Biology (FASEB), Keystone Symposia and IUPHAR meetings; he was the organizer of the 2012 GPCR Keystone Symposium. He has also been a regular consultant for major pharmaceutical companies including Merck, Eli Lilly, GSK, BMS, Amgen, Novartis, Astra-Zeneca, Sanofi and Organon; has held contracts for research with GSK and Pfizer, and currently leads a major collaborative research agreement with Servier. 

He is a Scientific Advisory Board member of 5 companies and 2 NIH Programs; has held sustained competitive research funding for over 10 years; is a member of the Executive of the Nomenclature Committee of the International Union of Pharmacology (NC-IUPHAR), and Chair of the NC-IUPHAR Muscarinic Receptor Nomenclature Subcommittee, as well as having been an Editorial Board member of 8 international journals, including current Associate (Handling) Editor duties for Molecular Pharmacology, Journal of Pharmacology & Experimental Therapeutics and Pharmacological Reviews.